Welcome to Markets Desk, here's what's moving the needle right now.
Geopolitical risk in the energy corridor remains front and center as U.S.-Iran ceasefire negotiations take shape, with outlines of a deal requiring Tehran to reopen the Strait of Hormuz in exchange for a lifted naval blockade. But experts warn Iran's regime is growing more suspicious precisely because the terms appear generous, raising the real possibility talks collapse before ink dries.
Meanwhile, Britain's Royal Navy sits anchored off Gibraltar, hundreds of sailors staged and ready for a mine-clearing operation in the strait, but under strict orders to wait until a formal peace agreement is secured. The deployment underscores just how seriously allied governments are treating the shipping disruption, which has hammered energy prices and global freight markets for weeks now.
On the consumer health side, patients relying on GLP-one weight loss medications like Ozempic and Wegovy are about to feel a sharper pinch at the pharmacy counter. These drugs are now the single largest driver of rising prescription spending, and insurers are responding by pushing co-payments higher, with some plans reconsidering coverage altogether. The downstream effect on pharmaceutical revenues and patient compliance is a story Wall Street will be watching closely.
That's the tape. Markets Desk, signing off the floor.
